[86] Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html [87] Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science , 72, Supplement 1, 186–187. [88] Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396. [89] Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science , 279, January. [90] Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat , 22, 91-100. [91] Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science , 279, 563–566. [92] Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science , 279, January. [93] Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet , 351, 9113, 9 May, 1373–1375. [94] Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services , 26, 1, 173–185. [95] Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461. [96] Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week , Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17th Street, N. W., Suite 413, Washington DC 20006. [97] The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.mt/comm/dg24/health/sc/scv/out19_en.html [98] D'Ercole, J. A., Underwood, L. E. and Van Wyk, J. J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth. J. Pediatr. , 90, 3, 375–381. See also Cullen, K. J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research , vol. 50, pp. 48–53. [99] De Leon, D. D., Wilson, D. M., Powers, M. and Rosenfeld, R. G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors , 6, 327–336. — 340 —
|